Prostate Cancer
-
More Prostate Cancer Patients Choose Surveillance
Men are increasingly opting to put off treatment for low-risk prostate cancer, and doctors say it’s a good thing.
by Kyle Bagenstose
-
Balancing Early-Stage Prostate Cancer Decisions
Choices about screening and treatment for early-stage prostate cancer are complex and largely personal.
by Kendall K. Morgan
-
An Emerging Treatment for Metastatic Prostate Cancer
A drug that delivers radioactive particles to prostate cancer cells increases overall survival for metastatic castration-resistant prostate cancer.
by Pamela Rafalow Grossman
-
Forward Look
What’s Next? Spring 2021
A new way to evaluate patients with prostate cancer.
by Christina Bennett
-
When Cancer’s Spread Is Limited
People with cancer that has spread to only a few locations—called oligometastatic cancer—may benefit from aggressive local treatment.
by Kate Yandell
-
Forward Look
Doing More With Less
Hypofractionation may allow patients to finish radiation treatment sooner.
by Stephen Ornes
-
The Pandemic’s Impact on Cancer Screening and Detection
Delays in cancer screening and diagnosis due to the COVID-19 pandemic put people at risk.
by Kevin McLaughlin
-
Robotic Surgery and Cancer
Using robotic assistants for cancer surgery has become commonplace. Whether cancer patients benefit when a surgeon uses a robot remains unclear.
by Sue Rochman
-
Survivor Profile
A Driving Force
Mark Good uses every avenue to spread the news about prostate cancer.
by Lindsey Konkel
-
For Prostate Biopsy, It’s Best to Combine Old and New Methods
Using an older method of prostate biopsy together with MRI-targeted biopsy more accurately diagnoses prostate cancer than either method alone, a study finds.
by Kate Yandell
